Vascular effects of loop diuretics

Cardiovascular Research

Volumn 32, Issue 6, 1996, Pages 988-997

  Dormans, Tom P J ^a   Pickkers, Peter ^a   Russel, Frans G M ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

angiotensin II; furosemide; loop diuretic; prostaglandin; salt depletion; venodilation

Indexed keywords

FUROSEMIDE; LOOP DIURETIC AGENT; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE A2;

ANIMAL EXPERIMENT; DIURESIS; DOG; HEART FAILURE; HEMODYNAMICS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASODILATATION;

ANIMALS; ARTERIES; DIURETICS; DOGS; ENDOTHELIUM, VASCULAR; HEART FAILURE, CONGESTIVE; HUMANS; PROSTAGLANDINS; RENIN-ANGIOTENSIN SYSTEM; SULFONAMIDES; VEINS;

EID: 0030444486     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00134-4     Document Type: Review

References (57)

1. O'Donnell ME, Owen NE. Regulation of ion pumps and carriers in vascular smooth muscle. Physiol Rev. 74:1994;683-721.
2. O'Donnell ME, Owen NE. Sodium cotransport in vascular smooth muscle cells. Blood Vessels. 28:1991;138-146.
3. 3H]Bumetanide binding in vascular endothelial cells. Quantitation of Na-K-Cl cotransporters. J Biol Chem. 264:1989;20326-20330.
4. Ellory JC, Stewart GW. The human erythrocyte Cl-dependent Na-K cotransport system as a possible model for studying the action of loop diuretics. Br J Pharmacol. 75:1982;183-188.
5. Blair West JR, McKinley MJ, McKenzie JS. Effect of frusemide on the reactivity of rat portal vein. J Pharm Pharmacol. 24:1972;442-446.
6. Kreye VA, Bauer PK, Villhauer I. Evidence for furosemide-sensitive active chloride transport in vascular smooth muscle. Eur J Pharmacol. 73:1981;91-95.
7. Handa M, Kondo K, Saruta T. Effects of diuretics on the vasoconstrictor responses to norepinephrine and potassium ions in the rat mesenteric artery. Arch Int Pharmacodyn Ther. 262:1983;124-131.
8. Andreasen F, Christensen JH. The effect of furosemide on vascular smooth muscle is influenced by plasma protein. Pharmacol Toxicol. 63:1988;324-326.
9. Tian R, Aalkjaer C, Andreasen F. Mechanisms behind the relaxing effect of furosemide on the isolated rabbit ear artery. Pharmacol Toxicol. 68:1991;406-410.
10. Greenberg S, McGowan C, Xie J, Summer WR. Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine. J Pharmacol Exp Ther. 270:1994;1077-1085.
11. Gerkens JF. Inhibitory effect of frusemide on sympathetic vasoconstrictor responses: dependence on a renal hormone and the vascular endothelium. Clin Exp Pharmacol Physiol. 14:1987;371-377.
12. Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJ. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med. 288:1973;1087-1090.
13. Bourland WA, Day DK, Williamson HE. The role of the kidney in the early nondiuretic action of furosemide to reduce elevated left atrial pressure in the hypervolemic dog. J Pharmacol Exp Ther. 202:1977;221-229.
14. Cantarovich F, Benedetti L, Fernandez JC, et al. High doses of furosemide and sodium in hypertension. A single therapeutic measure in severe cases. Nephron. 12:1974;133-139.
15. Niarchos AP, Magrini F. Hemodynamic effects of diuretics in patients with marked peripheral edema and mild hypertension. Clin Pharmacol Ther. 31:1982;370-376.
16. Hesse B, Nielsen I, Lund Jacobsen H. The early effects of intravenous frusemide on central haemodynamics, venous tone and plasma renin activity. Clin Sci Mol Med. 49:1975;551-555.
17. Ikram H, Chan W, Espiner EA, Nicholls MG. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci. 59:1980;443-449.
18. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med. 103:1985;1-6.
19. Struyker Boudier HA, Smits JF, Kleinjans JC, van Essen H. Hemodynamic actions of diuretic agents. Clin Exp Hypertens A. 5:1983;209-223.
20. Johnston GD, Nicholls DP, Leahey WJ. The dose-response characteristics of the acute non-diuretic peripheral vascular effects of frusemide in normal subjects. Br J Clin Pharmacol. 18:1984;75-81.
21. Mukherjee SK, Katz MA, Michael UF, Ogden DA. Mechanisms of hemodynamic actions of furosemide: differentiation of vascular and renal effects on blood pressure in functionally anephric hypertensive patients. Am Heart J. 101:1981;313-318.
22. Johnston GD, Hiatt WR, Nies AS, Payne NA, Murphy RC, Gerber JG. Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res. 53:1983;630-635.
23. Gerkens JF, Smith AJ. Inhibition of vasoconstriction by frusemide in the rat. Br J Pharmacol. 83:1984;363-371.
24. Gerkens JF, Armsworth SJ, Bhagwandeen SB, Smith AJ. Chemical renal medullectomy prevents frusemide-induced inhibition of sympathetic vasoconstriction in the in situ blood perfused rat mesentery. J Hypertens. 5:1987;273-275.
25. Gerkens JF, Armsworth SJ, Dosen PJ, Smith AJ. Endothelium-dependent inhibition of sympathetic vasoconstriction by frusemide administration to rats. Clin Exp Pharmacol Physiol. 15:1988;449-455.
26. Davis JO, Freeman RH. Mechanisms regulating renin release. Physiol Rev. 56:1976;1-56.
27. Oates JA, Whorton AR, Gerkens JF, Branch RA, Hollifield JW, Frolich JC. The participation of prostaglandins in the control of renin release. Fed Proc. 38:1979;72-74.
28. Patrono C, Pugliese F. The involvement of arachidonic acid metabolism in the control of renin release. J Endocrinol Invest. 3:1980;193-201.
29. Francisco LL, Osborn JL, DiBona GF. Prostaglandin in renin release during sodium deprivation. Am J Physiol. 243:1982;F537-F542.
30. Data JL, Rane A, Gerkens J, Wilkinson GR, Nies AS, Branch RA. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog. J Pharmacol Exp Ther. 206:1978;431-438.
31. Kopp U, Aurell M, Sjolander M, Ablad B. The role of prostaglandins in the alpha- and beta-adrenoceptor mediated renin release response to graded renal nerve stimulation. Pflügers Arch. 391:1981;1-8.
32. Gerber JG, Nies AS, Olsen RD. Control of canine renin release: macula densa requires prostaglandin synthesis. J Physiol. 319:1981;419-429.
33. He XR, Greenberg SG, Briggs JP, Schnermann J. Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion. Hypertension. 26:1995;137-142.
34. Barden AE, Mahoney DP, Tunney AM, Vandongen R. Frusemide releases renin in the rat kidney when prostacyclin synthesis is suppressed. Br J Pharmacol. 82:1984;493-499.
35. Packer M. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure. Circulation. 77:1988;I64-I73.
36. Johnston GD, Nicholls DP, Leahey WJ, Finch MB. The effects of captopril on the acute vascular responses to frusemide in man. Clin Sci. 65:1983;359-363.
37. Collier JG, Robinson BF. Comparison of effects of locally infused angiotensin I and II on hand veins and forearm arteries in man: evidence for converting enzyme activity in limb vessels. Clin Sci Mol Med. 47:1974;189-192.
38. Passmore AP, Whitehead EM, Johnston GD. Comparison of the acute renal and peripheral vascular responses to frusemide and bumetanide at low and high dose. Br J Clin Pharmacol. 27:1989;305-312.
39. Johnston GD, Nicholls DP, Kondowe GB, Finch MB. Comparison of the acute vascular effects of frusemide and bumetanide. Br J Clin Pharmacol. 21:1986;359-364.
40. Gerber JG, Nies AS. Furosemide-induced vasodilation: importance of the state of hydration and filtration. Kidney Int. 18:1980;454-459.
41. Williamson HE, Bourland WA, Marchand GR. Inhibition of furosemide induced increase in renal blood flow by indomethacin. Proc Soc Exp Biol Med. 148:1975;164-167.
42. Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int. 32:1987;1-12.
43. Wiemer G, Fink E, Linz W, Hropot M, Scholkens BE, Wohlfart P. Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin. J Pharmacol Exp Ther. 271:1994;1611-1615.
44. Gerber JG, Hubbard WC, Branch RA, Nies AS. The lack of an effect of furosemide on uterine prostaglandin metabolism in vivo. Prostaglandins. 15:1978;663-670.
45. Bailie MD, Crosslan K, Hook JB. Natriuretic effect of furosemide after inhibition of prostaglandin synthetase. J Pharmacol Exp Ther. 199:1976;469-476.
46. Horrobin DF, Manku MS, Mtabaji JP. Vascular actions of frusemide and bumetanide on the rat superior mesenteric vascular bed: interactions with prostaglandins. Clin Sci Mol Med Suppl. 3:1976;257s-258s.
47. Lundergan CF, Fitzpatrick TM, Rose JC, Ramwell PW, Kot PA. Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide. J Pharmacol Exp Ther. 246:1988;102-106.
48. Mackay IG, Muir AL, Watson ML. Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man. Br J Clin Pharmacol. 17:1984;513-519.
49. Mtabaji JP, Manku MS, Horrobin DF. Vascular actions of furosemide and bumetanide on the rat superior mesenteric vascular bed: interactions with prolactin and prostaglandins. Can J Physiol Pharmacol. 54:1976;357-366.
50. Scherer B, Weber PC. Time-dependent changes in prostaglandin excretion in response to frusemide in man. Clin Sci. 56:1979;77-81.
51. 2-like activity from the rat aorta: effect of captopril, furosemide, and sodium. Prostaglandins. 22:1981;575-585.
52. 2. Am J Physiol. 247:1984;F555-F561.
53. Yared A, Kon V, Ichikawa I. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin. J Clin Invest. 75:1985;1477-1487.
54. Patrono C, Pugliese F, Ciabattoni G, et al. Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest. 69:1982;231-239.
55. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 25:1995;918-923.
56. Aellig WH. Clinical pharmacology, physiology and pathophysiology of superficial veins - 1. Br J clin Pharmacol. 38:1994;181-196.
57. Aellig WH. Clinical pharmacology, physiology and pathophysiology of superficial veins - 2. Br J Clin Pharmacol. 38:1994;289-305.